Neumora Therapeutics NMRA SEC Filings

NASDAQ NMRA
$0.47 +0.01 (+1.37%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Neumora Therapeutics, Inc. (NMRA) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001193125-26-441634Oct 30, 2026 4:05 PM
24Insider Transaction0001610717-26-000385Aug 21, 2026 11:10 PM
34Insider Transaction0001610717-26-000384Aug 21, 2026 11:10 PM
44Insider Transaction0001610717-26-000383Aug 21, 2026 11:08 PM
54Insider Transaction0001610717-26-000382Aug 21, 2026 11:08 PM
64Insider Transaction0001610717-26-000381Aug 21, 2026 11:06 PM
7144Insider Transaction0001964306-26-000408Aug 21, 2026 8:34 PM
8144Insider Transaction0001964306-26-000403Aug 20, 2026 8:22 PM
94Insider Transaction0001610717-26-000362Aug 19, 2026 11:17 PM
10144Insider Transaction0001964306-26-000401Aug 19, 2026 8:19 PM
11144Insider Transaction0001964306-26-000400Aug 18, 2026 8:32 PM
12144Insider Transaction0001964306-26-000398Aug 17, 2026 9:25 PM
1310-QQuarterly & Annual Report0001193125-26-350370Aug 14, 2026 11:23 AM
148-KCurrent Report0001193125-26-350349Aug 14, 2026 11:13 AM
158-KCurrent Report0001193125-26-316819Jul 27, 2026 11:07 AM
168-KCurrent Report0001193125-26-270328Jun 15, 2026 12:15 PM
174Insider Transaction0001610717-26-000174May 29, 2026 8:34 PM
184Insider Transaction0001610717-26-000173May 29, 2026 8:30 PM
194Insider Transaction0001610717-26-000171May 29, 2026 8:22 PM
204Insider Transaction0001610717-26-000170May 29, 2026 8:21 PM
214Insider Transaction0001610717-26-000169May 29, 2026 8:21 PM
228-KCurrent Report0001193125-26-248244May 29, 2026 8:05 PM
23SCHEDULE 13GBeneficial Ownership Report0000905148-26-002417May 15, 2026 9:16 PM
2410-QQuarterly & Annual Report0001193125-26-211825May 7, 2026 8:01 PM
258-KCurrent Report0001193125-26-210310May 7, 2026 11:10 AM
26SCHEDULE 13GBeneficial Ownership Report0002005369-26-000023May 4, 2026 6:08 PM
27DEFA14AOthers0001193125-26-161519Apr 17, 2026 8:05 PM
28DEF 14AOthers0001193125-26-161489Apr 17, 2026 8:04 PM
29SCHEDULE 13DBeneficial Ownership Report0001012975-26-000294Apr 1, 2026 8:10 PM
30S-8Prospectus0001193125-26-130407Mar 30, 2026 11:20 AM
3110-KQuarterly & Annual Report0001193125-26-130388Mar 30, 2026 11:07 AM
328-KCurrent Report0001193125-26-130372Mar 30, 2026 10:58 AM
334Insider Transaction0001610717-26-000054Feb 19, 2026 10:07 PM
344Insider Transaction0001610717-26-000053Feb 19, 2026 10:06 PM
354Insider Transaction0001610717-26-000052Feb 19, 2026 10:05 PM
364Insider Transaction0001610717-26-000051Feb 19, 2026 10:04 PM
37SCHEDULE 13GBeneficial Ownership Report0002005369-26-000014Feb 19, 2026 9:37 PM
38SCHEDULE 13GBeneficial Ownership Report0000905148-26-000895Feb 17, 2026 9:41 PM
39144Insider Transaction0001964306-26-000112Feb 17, 2026 9:25 PM
40144Insider Transaction0001964306-26-000111Feb 17, 2026 9:24 PM
41144Insider Transaction0001964306-26-000110Feb 17, 2026 9:23 PM
42144Insider Transaction0001964306-26-000109Feb 17, 2026 9:21 PM
438-KCurrent Report0001193125-26-045526Feb 11, 2026 12:00 PM
448-KCurrent Report0001193125-26-009727Jan 12, 2026 12:00 PM
454Insider Transaction0001610717-26-000014Jan 9, 2026 9:20 PM
464Insider Transaction0001610717-26-000011Jan 9, 2026 9:19 PM
474Insider Transaction0001610717-26-000010Jan 9, 2026 9:18 PM
484Insider Transaction0001610717-26-000009Jan 9, 2026 9:18 PM
494Insider Transaction0001610717-26-000008Jan 9, 2026 9:17 PM
508-KCurrent Report0001193125-26-001472Jan 5, 2026 11:44 AM
...

Neumora Therapeutics, Inc. SEC Filings API

Pull Neumora Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=NMRA&formtype=10-K,10-Q&api_key=YOUR_API_KEY